Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Return on assets

Return on assets at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-3.1%-7.1pp
Alkermes logo
AlkermesALKS
4.8%-12.0pp
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-28.7%-8.4pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-39.9%-56.4pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
3.5%+3.2pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
27.4%+4.4pp

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

net income/total assets=12.5%

Based on trailing twelve months.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s return on assets?
Harmony Biosciences Holdings, Inc. (HRMY) reported return on assets of 12.5% in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s return on assets changed year-over-year?
Harmony Biosciences Holdings, Inc.'s return on assets decreased by 22.1% year-over-year, from 16.1% to 12.5%.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s return on assets?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s return on assets has grown at a 0.2% compound annual growth rate (CAGR), from -13.8% to 14%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.